Patient advocacy organizations’ information for patients on pre-approval access to investigational treatments
Abstract Objective To evaluate the availability of information regarding patient access to investigational treatments through clinical trials and non-trial pre-approval access pathways from a sample of patient advocacy organization (PAO) websites in the United States. Results We systematically analy...
Main Authors: | Kelly McBride Folkers, Sarah Leone, Arthur Caplan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-019-4745-7 |
Similar Items
-
Characterizing expanded access and compassionate use programs for experimental drugs
by: Jennifer E. Miller, et al.
Published: (2017-07-01) -
Game Accessibility and Advocacy for Participation of the Japanese Disability Community
by: Muneo Kaigo, et al.
Published: (2020-03-01) -
Barriers to Advocacy and Litigation in the Equality Courts for Persons with Disabilities
by: Willene Holness, et al.
Published: (2014-12-01) -
Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations
by: Brooke E. Wilson, et al.
Published: (2021-08-01) -
Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications
by: Hye-Young Kwon, et al.
Published: (2018-09-01)